Vaxcyte Inc (PCVX)
74.60
-0.85
(-1.13%)
USD |
NASDAQ |
May 17, 16:00
74.60
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Price to Book Value: 4.089 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 4.089 |
| May 16, 2024 | 4.137 |
| May 15, 2024 | 3.928 |
| May 14, 2024 | 3.692 |
| May 13, 2024 | 3.603 |
| May 10, 2024 | 3.575 |
| May 09, 2024 | 3.596 |
| May 08, 2024 | 3.662 |
| May 07, 2024 | 3.703 |
| May 06, 2024 | 3.641 |
| May 03, 2024 | 3.616 |
| May 02, 2024 | 3.538 |
| May 01, 2024 | 3.492 |
| April 30, 2024 | 3.319 |
| April 29, 2024 | 3.346 |
| April 26, 2024 | 3.329 |
| April 25, 2024 | 3.292 |
| April 24, 2024 | 3.306 |
| April 23, 2024 | 3.337 |
| April 22, 2024 | 3.377 |
| April 19, 2024 | 3.335 |
| April 18, 2024 | 3.323 |
| April 17, 2024 | 3.422 |
| April 16, 2024 | 3.412 |
| April 15, 2024 | 3.420 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.392 |
| April 11, 2024 | 3.554 |
| April 10, 2024 | 3.428 |
| April 09, 2024 | 3.536 |
| April 08, 2024 | 3.513 |
| April 05, 2024 | 3.508 |
| April 04, 2024 | 3.473 |
| April 03, 2024 | 3.569 |
| April 02, 2024 | 3.532 |
| April 01, 2024 | 3.658 |
| March 28, 2024 | 5.970 |
| March 27, 2024 | 5.986 |
| March 26, 2024 | 5.892 |
| March 25, 2024 | 5.800 |
| March 22, 2024 | 5.875 |
| March 21, 2024 | 5.911 |
| March 20, 2024 | 6.041 |
| March 19, 2024 | 5.908 |
| March 18, 2024 | 5.946 |
| March 15, 2024 | 6.091 |
| March 14, 2024 | 6.055 |
| March 13, 2024 | 6.402 |
| March 12, 2024 | 6.259 |
| March 11, 2024 | 6.139 |
| March 08, 2024 | 6.353 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.585
Minimum
May 10 2021
13.05
Maximum
Jun 19 2020
4.485
Average
3.956
Median
Price to Book Value Benchmarks
| Apellis Pharmaceuticals Inc | 18.80 |
| Alnylam Pharmaceuticals Inc | -- |
| Cytokinetics Inc | -- |
| Exelixis Inc | 2.862 |
| Incyte Corp | 2.377 |
Price to Book Value Related Metrics
| Price | 74.60 |
| Earnings Yield | -6.57% |
| Market Cap | 8.113B |